ACE2 and COVID-19: Thus, based on the high ACE2 expression found in human CB, it is plausible that the SARS-CoV-2 infection of chemosensory glomus cells could alter their ability to detect changes in arterial O2 tension, resulting in unawareness of hypoxemia as occurs in case of “silent hypoxemia” observed in COVID-19 patients.